Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-180,000
Closed -$2.63M 227
2026
Q1
$2.63M Sell
180,000
-177,953
-50% -$2.61M 0.14% 96
2025
Q4
$4.52M Buy
+357,953
New +$5.28M 0.2% 89
2024
Q4
Sell
-149,800
Closed -$4.19M 233
2024
Q3
$4.19M Sell
149,800
-140,200
-48% -$3.96M 0.32% 67
2024
Q2
$7.58M Sell
290,000
-210,000
-42% -$4.37M 0.57% 48
2024
Q1
$10.9M Sell
500,000
-90,000
-15% -$1.93M 0.8% 39
2023
Q4
$13.7M Sell
590,000
-60,000
-9% -$1.21M 1.12% 36
2023
Q3
$12.8M Buy
650,000
+295,000
+83% +$5.81M 1% 31
2023
Q2
$8.05M Buy
355,000
+105,000
+42% +$2.11M 0.58% 48
2023
Q1
$4.91M Hold
250,000
0.37% 71
2022
Q4
$4.3M Buy
+250,000
New +$4.43M 0.36% 71

Other funds holding RXO

683 Capital Management's RXO Position: Q2 2026 in Review

683 Capital Management sold out of RXO (RXO) in Q2 2026, closing a stake of 180,000 shares — an estimated $2.63M sold.

683 Capital Management first reported a position in RXO in Q4 2022 and held it in 10 quarters. The position peaked at $13.7M in Q4 2023. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • 683 Capital Management reported no remaining RXO position as of Q2 2026 after selling out during the quarter.
  • 683 Capital Management sold 180,000 RXO shares in Q2 2026, an estimated $2.63M.
  • 683 Capital Management first reported a position in RXO in Q4 2022 and held it in 10 quarters.
  • 683 Capital Management's RXO position peaked at $13.7M in Q4 2023.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.